As of 2025-07-11, the Relative Valuation of WuXi Biologics (Cayman) Inc (2269.HK) is 22.02 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 25.70 HKD, the upside of WuXi Biologics (Cayman) Inc based on Relative Valuation is -14.3%.
The range of the Relative Valuation is 17.78 - 24.65 HKD.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 25.6x | 22.2x |
| Forward P/E multiples | 18.2x - 18.9x | 18.3x |
| Fair Price | 17.78 - 24.65 | 22.02 |
| Upside | -30.8% - -4.1% | -14.3% |
| Date | P/E |
| 2025-07-10 | 223.05 |
| 2025-07-09 | 224.78 |
| 2025-07-08 | 223.05 |
| 2025-07-07 | 217.40 |
| 2025-07-04 | 227.39 |
| 2025-07-03 | 223.91 |
| 2025-07-02 | 222.61 |
| 2025-06-30 | 222.61 |
| 2025-06-27 | 218.27 |
| 2025-06-26 | 216.97 |
| 2025-06-25 | 223.05 |
| 2025-06-24 | 220.44 |
| 2025-06-23 | 212.63 |
| 2025-06-20 | 209.16 |
| 2025-06-19 | 209.16 |
| 2025-06-18 | 215.67 |
| 2025-06-17 | 223.05 |
| 2025-06-16 | 229.99 |
| 2025-06-13 | 243.01 |
| 2025-06-12 | 240.84 |
| 2025-06-11 | 231.29 |
| 2025-06-10 | 230.42 |
| 2025-06-09 | 225.65 |
| 2025-06-06 | 213.93 |
| 2025-06-05 | 216.10 |
| 2025-06-04 | 218.71 |
| 2025-06-03 | 214.37 |
| 2025-06-02 | 216.54 |
| 2025-05-30 | 216.54 |
| 2025-05-29 | 223.48 |
| 2025-05-28 | 203.08 |
| 2025-05-27 | 205.69 |
| 2025-05-26 | 200.48 |
| 2025-05-23 | 206.99 |
| 2025-05-22 | 208.73 |
| 2025-05-21 | 214.37 |
| 2025-05-20 | 209.59 |
| 2025-05-19 | 206.12 |
| 2025-05-16 | 204.39 |
| 2025-05-15 | 206.99 |
| 2025-05-14 | 206.56 |
| 2025-05-13 | 200.92 |
| 2025-05-12 | 201.78 |
| 2025-05-09 | 200.48 |
| 2025-05-08 | 195.71 |
| 2025-05-07 | 188.33 |
| 2025-05-06 | 201.78 |
| 2025-05-02 | 209.16 |
| 2025-04-30 | 197.88 |
| 2025-04-29 | 200.48 |